Your Article Summary
Effects of bevacizumab on plasma concentration of irinotecan and its metabolites in advanced colorectal cancer patients receiving FOLFIRI with bevacizumab as second-line chemotherapy
Cancer Chemotherapy and Pharmacology, 06/30/09
Horita Y et al. - BV does not affect the plasma concentration of CPT-11 and its metabolites on FOLFIRI regimen.
Related Articles
Colorectal cancer incidence and postmenopausal hormone use by type, recency, and duration in cancer prevention study II
Cancer Epidemiology, Biomarkers & Prevention, 10/28/09
Relevance Score: 72%
Association of IGF1 and IGFBP3 polymorphisms with colorectal polyps and colorectal cancer risk
Cancer Causes and Control, 10/02/09
Relevance Score: 72%
P73 expression and its clinical significance in colorectal cancer
Colorectal Disease, 10/19/09
Relevance Score: 71%
trans-Fatty acid consumption and its association with distal colorectal cancer in the North Carolina Colon Cancer Study II
Cancer Causes and Control, 10/28/09
Relevance Score: 70%
Association of clinicopathological features with UbcH10 expression in colorectal cancer
Journal of Cancer Research & Clinical Oncology, 10/01/09
Relevance Score: 70%
Today in Colorectal Cancer/Polyps...keeping you current
Receive free subspecialty "5-minute updates" via email
Src family tyrosine kinases-driven colon cancer cell invasion is induced by Csk membrane delocalization
Oncogene, 12/16/09
Polymorphisms in the transforming growth factor beta 1 pathway in relation to colorectal cancer progression
Genes, Chromosomes and Cancer, 12/16/09
Comprehensive geriatric assessment can predict complications in elderly patients after elective surgery for colorectal cancer: A prospective observational cohort study
Critical Reviews in Oncology/Hematology, 12/16/09
Today in Pharmacology/Therapy...keeping you current
Receive free subspecialty "5-minute updates" via email
Port central venous catheters–associated bloodstream infection during outpatient-based chemotherapyTEST
Medical Oncology, 12/17/09
Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiformeTEST
Journal of Neuro-Oncology, 12/17/09
CDK inhibitors as potential breast cancer therapeutics: new evidence for enhanced efficacy in ER+ disease
Breast Cancer Research, 12/16/09

See Latest Articles